Please use this identifier to cite or link to this item:
https://hdl.handle.net/10216/159485| Author(s): | Alexandra Margarida Pereira e Silva |
| Title: | EpiRPCter - Epidemiology of Autosomal Dominant Polycystic Kidney Disease among patients incident on first renal replacement therapy between 1990-2020, in a major University Hospital in the Northwest of Portugal |
| Issue Date: | 2024-06-07 |
| Abstract: | Background and hypothesis Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common monogenic kidney disease, being the cause of the kidney failure (KF) in 5-10% of incident patients in renal replacement therapy (RRT). ADPKD is genetically heterogenous, but pathogenic variants in the genes encoding polycystin-1 ('PKD1') and polycystin-2 ('PKD2') explain most cases (respectively ~78% and ~15%). Clinical experience at São João University Hospital Centre (CHUSJ) suggests that the relative prevalence of ADPKD-'PKD2' is significantly higher than reported, mainly due to a polycystin-2 truncating mutation - 'PKD2' p.(Gln61*). The purpose of this study was to describe the epidemiology of ADPKD among patients starting RRT at CHUSJ, and to compare ADPKD-'PKD1' to ADPKD-'PKD2'. Methods Medical reports for RRT initiation (MR-RRT) issued at the CHUSJ between 01/01/1990-31/12/2020 were systematically reviewed to identify patients diagnosed with ADPKD. Genotyping data were obtained from the Genetics Laboratory of the Faculty of Medicine, University of Porto. For patients who not been directly tested, the genotype was inferred from genealogical analysis. Data from non-ADPKD patients starting RRT between 2010-2020 were collected for selected comparisons with the general RRT population. Results Out of 6244 medical reports reviewed, 376 ADPKD patients were identified; of the latter, 125 (33.2%) had genotyping information available, which was imputed in 79 (63.2%). Among genotyped patients, prevalences of ADPKD-'PKD1' and ADPKD-'PKD2' were, respectively, 65.6% and 29.8%. Mean age at RRT initiation was 53.6 years for ADPKD-'PKD1' patients and 68.0 years for ADPKD-'PKD2'. Heterozygosity for the 'PKD2' p.Gln61* allele was identified in 30 patients. Between 2010-2020, prevalence of ADPKD was 7.19% at CHUSJ and 4.71% nationwide (p<.001). Conclusion Prevalence of ADPKD among patients incident on RRT at CHUSJ was significantly higher than nationwide. ADPKD-'PKD1' was associated with KF significantly earlier than ADPKD-'PKD2'. 'PKD2' p.(61Gln*) was the most prevalent pathogenic variant identified in our cohort. |
| Description: | Contextualização e hipóteses A Doença Renal Policística Autossómica Dominante (DRPAD) é a doença renal monogénica mais comum, sendo causa de insuficiência renal em 5-10% dos doentes incidentes em tratamento de substituição da função renal (TSFR). A DRPAD é geneticamente heterogénea, mas variantes patogénicas nos genes que codificam a policistina-1 ('PKD1') e policistina-2 ('PKD2') explicam a maioria dos casos (respetivamente ~78% e ~15%). A experiência clínica no Centro Hospitalar Universitário de São João (CHUSJ) sugere que a prevalência relativa da DRPAD-'PKD2' é significativamente superior à reportada na literatura, principalmente devido a uma mutação truncadora da policistina-2 - 'PKD2' p.(Gln61*). O objetivo deste estudo foi descrever a epidemiologia da DRPAD em doentes incidentes em TSFR no CHUSJ, e comparar DRPAD-'PKD1' com DRPAD-'PKD2'. Métodos Relatórios médicos para início de TSFR emitidos no CHUSJ entre 01/01/1990 e 31/12/2020 foram sistematicamente revistos para identificar indivíduos diagnosticados com DRPAD. Dados de genotipagem foram obtidos no Laboratório de Genética da Faculdade de Medicina da Universidade do Porto. Para os doentes não testados diretamente, o genótipo foi inferido a partir de análise genealógica. Dados de indivíduos sem DRPAD incidentes em TSFR entre 2010 e 2020 foram recolhidos para comparações selecionadas com a população geral em TSFR. Resultados De 6244 relatórios médicos revistos, 376 doentes com DRPAD foram identificados; destes, 125 (33,2%) tinham informação de genotipagem disponível, sendo imputada em 79 (63,2%). Entre os pacientes genotipados, as prevalências de DRPAD-'PKD1' e DRPAD-'PKD2' foram, respetivamente, 65,6% e 29,8%. A idade média de início da TSFR foi de 53,6 anos para indivíduos com DRPAD-'PKD1' e 68,0 anos para pacientes com DRPAD-'PKD2'. Heterozigotia para o alelo 'PKD2' p.Gln61* foi identificada em 30 pacientes. Entre 2010 e 2020, a prevalência de DRPAD foi de 7,19% no CHUSJ e 4,71% em todo o país (p=0,0001). Conclusão A prevalência de DRPAD entre pacientes incidentes em TSFR no CHUSJ foi significativamente maior do que a nível nacional. A DRPAD-'PKD1' foi associada a insuficiência renal significativamente mais precoce do que a DRPAD-'PKD2'. 'PKD2' p.(61Gln*) foi a variante patogénica mais prevalente identificada na nossa coorte. |
| Subject: | Medicina clínica Clinical medicine |
| Scientific areas: | Ciências médicas e da saúde::Medicina clínica Medical and Health sciences::Clinical medicine |
| DOI: | 10.34626/e7gx-1491 |
| TID identifier: | 203750799 |
| URI: | https://hdl.handle.net/10216/159485 |
| Document Type: | Dissertação |
| Rights: | restrictedAccess |
| License: | https://creativecommons.org/licenses/by-nc-nd/4.0/ |
| Appears in Collections: | FMUP - Dissertação |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 678756.pdf Restricted Access | EpiRPCter - Epidemiology of Autosomal Dominant Polycystic Kidney Disease among patients incident on first renal replacement therapy between 1990-2020, in a major University Hospital in the North | 2.19 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License